
Aristo Bio-Tech And Lifescience Limited
The current stock price of Aristo Bio-Tech And Lifescience Limited is ₹91.30, with a target price range between ₹86.74 and ₹95.87. The stock has experienced a price change of ₹0.00 (0.00%), reflecting recent market volatility.
Today's opening price was ₹0.00, while the previous close stood at ₹91.30.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Aristo Bio-Tech And Lifescience Limited Price Chart
Aristo Bio-Tech And Lifescience Limited Pre Open Market Overview: 13-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 0
- Previous Close Price: 91.3
- Change: -91.30%
- Total Traded Volume: 0
- Total Buy Quantity: 6,400
- Total Sell Quantity: 3,200
Price | Buy Qty | Sell Qty |
---|---|---|
0.00 | 0.00 | 0.00 |
74.25 | 1,600.00 | 0.00 |
80.00 | 1,600.00 | 0.00 |
85.00 | 1,600.00 | 0.00 |
90.00 | 1,600.00 | 0.00 |
100.00 | 0.00 | 1,600.00 |
109.55 | 0.00 | 1,600.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 1,600
Order Book
Bid | Qty | Ask | Qty |
---|---|---|---|
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
Shareholding Patterns of Aristo Bio-Tech And Lifescience Limited
Key Trade Statistics of Aristo Bio-Tech And Lifescience Limited
Trade Information | Details |
---|---|
Traded Volume (Lakhs) | N/A |
Traded Value (₹ Cr.) | N/A |
Total Market Cap (₹ Cr.) | 62.16 |
Free Float Market Cap (₹ Cr.) | 16.55 |
Impact cost | N/A |
Quantity Traded | 1,600.00 |
Deliverable Quantity | 1,600.00 |
% of Quantity to Traded | 100 |
Security VaR | N/A |
Index VaR | N/A |
VaR Margin | 50 |
Extreme Loss Rate | 3.5 |
Adhoc Margin | N/A |
Applicable Margin Rate | 53.5 |
Face Value | 10 |
Key Price Statistics of Aristo Bio-Tech And Lifescience Limited
The 52-week high for Aristo Bio-Tech And Lifescience Limited was ₹164.00, recorded on 06-Nov-2024. On the other hand, the 52-week low stands at ₹53.10, with the lowest value recorded on 14-Mar-2024.
The upper band for trading is ₹109.55, and the lower band is ₹73.05. The price band is 20%.
The stock's daily volatility stands at N/A, while the annualized volatility is N/A. The tick size for trading is ₹0.05.
Price Information | Details |
---|---|
52 Week High (06-Nov-2024) | 164.00 |
52 Week Low (14-Mar-2024) | 53.10 |
Upper Band | 109.55 |
Lower Band | 73.05 |
Price Band (%) | 20 |
Daily Volatility | - |
Annualised Volatility | - |
Tick Size | 0.05 |
Key Securities Statistics of Aristo Bio-Tech And Lifescience Limited
Securities Information | Details |
---|---|
Status | Listed |
Trading Status | Active |
Date of Listing | 30-Jan-2023 |
Adjusted P/E | NA |
Symbol P/E | NA |
Index | NIFTY SME EMERGE |
Macro-Economic Sector | Commodities |
Sector | Chemicals |
Industry | Fertilizers & Agrochemicals |
Basic Industry | Pesticides & Agrochemicals |
Security Status of Aristo Bio-Tech And Lifescience Limited
Title | Details |
---|---|
Board Status | SME |
Trading Segment | Normal Market |
Session No. | - |
Class of Shares | Equity |
SDD Compliance | - |
Name of Compliance Officer | - |
Announcements of Aristo Bio-Tech And Lifescience Limited
Subject | Date |
---|---|
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 10-Mar-2025 |
Appointment | 10-Mar-2025 |
Appointment | 10-Mar-2025 |
Outcome of Board Meeting | 10-Mar-2025 |
Updates | 25-Feb-2025 |
Bagging/Receiving of orders/contracts | 13-Feb-2025 |
Bagging/Receiving of orders/contracts | 12-Feb-2025 |
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter | 11-Jan-2025 |
Corporate Actions of Aristo Bio-Tech And Lifescience Limited
Face Value | Purpose | Ex-Date |
---|---|---|
10 | DIVIDEND - RE 0.40 PER SHARE | 13-Sep-2024 |
10 | DIVIDEND - RE 0.25 PER SHARE | 15-Sep-2023 |
Board Meetings of Aristo Bio-Tech And Lifescience Limited
Financial Results of Aristo Bio-Tech And Lifescience Limited
Company Directory of Aristo Bio-Tech And Lifescience Limited
Web Address | Office | Address | City |
---|---|---|---|
- | Registered Address | E-24, 25, 26, G.I.D.C., Manjusar Ta. Savli,Vadodara ?? 391775, Gujarat, India. SAVLI - 391775 VADODARA | SAVLI |
- | Transfer Agent | C-101, 1 Floor, 247 Park, L.B.S. Marg, Vikhroli Mumbai- 400083, Maharashtra, India MUMBAI - 400083 MUMBAI | MUMBAI |
Insider Trading of Aristo Bio-Tech And Lifescience Limited
Reg. Clause | Acq./Disp. | Sec. Value | Txn Type | ||
---|---|---|---|---|---|
No insider trading information available |
Annual Reports of Aristo Bio-Tech And Lifescience Limited
Company | From Year | To Year | Att. |
---|---|---|---|
Aristo Bio-Tech And Lifescience Limited | 2023 | 2024 | |
Aristo Bio-Tech And Lifescience Limited | 2022 | 2023 |
Investor Complaints of Aristo Bio-Tech And Lifescience Limited
Event Calendar of Aristo Bio-Tech And Lifescience Limited
Purpose | Details |
---|---|
Board Meeting Intimation | ARISTO BIO-TECH AND LIFESCIENCE LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2024 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2024 and Other business. |
Financial Results/Other business matters | ARISTO : 14-Nov-2024 : The Company has informed the Exchange that a Board meeting to be held on November 13, 2024 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 14, 2024, To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
Board Meeting Intimation | ARISTO BIO-TECH AND LIFESCIENCE LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2024 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2024 and Other business. |
Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
ARISTO BIO-TECH AND LIFESCIENCE LIMITED has informed the Exchange about Board Meeting to be held on 27-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend/Other business. | Board Meeting Intimation |
Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2024, dividend and other business matters |
ARISTO BIO TECH AND LIFESCIENCE LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2023 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2023 and Other business. | Board Meeting Intimation |
Financial Results/Other business matters | Intimation of Board meeting for consideration of Unaudited Financial Results of the Company for the Half year ended on September 30, 2023. |
Financial Results/Dividend | has informed the Exchange about Board Meeting to be held on 27 May 2023 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2023 and Dividend/Other business. |
Share Transfers of Aristo Bio-Tech And Lifescience Limited
Company | Period | Reg.7 | Reg.40 |
---|---|---|---|
Aristo Bio Tech And Lifescience Limited | 31-MAR-2024 | ||
Aristo Bio Tech And Lifescience Limited | 31-MAR-2023 |
Voting Results of Aristo Bio-Tech And Lifescience Limited
Date of Mtg. | Mtg. Type | Resolution |
---|---|---|
20-SEP-2024 | AGM | To receive, consider and adopt the audited standalone financial statement of the Company for the financial year endednMarch 31, 2024 and the reports of the Board of Directors and Auditors thereon |
20-SEP-2024 | AGM | To ratify the remuneration payable to M/s. YS Thakar & Co., Cost Accountants, (Firm Registration Number: 000318) Cost Auditor of the Company for the Financial Year ended on March 31, 2025 |
20-SEP-2024 | AGM | To declare a final dividend of Rs. 0.4 per share (Rupees Forty Paisa only) per Equity share of Rs. 10/- each for the financial year ended on March 31, 2024. |
20-SEP-2024 | AGM | Appointment of Ms. Kusum Narendra Singh Barhat (DIN: 00310065), as executive director who retires by rotation and being eligible offers herself for re-appointment |
26-SEP-2023 | AGM | To consider and adopt the audited standalone financial statement of the Company for the financial year ended March 31, 2023 and the reports of the Board of Directors and Auditors thereon; |
26-SEP-2023 | AGM | Appointment of Mr. Dipakkumar Harkantbhai Joshi (Din: 08549339), As Director Who Retires By Rotation And Being Eligible, Seeks Re-Appointment. |
26-SEP-2023 | AGM | To declare a final dividend of ᅡ0.25 per share (Twenty-Five Paise only) per Equity share of Rs. 10/- each for the financial year ended on March 31, 2023 |
26-SEP-2023 | AGM | To Ratify the Remuneration Payable to M/S. YS Thakar & Co., Cost Accountants, (Firm Registration Number:000318) Cost Auditor of the Company for the Financial Year Ended on March 31, 2024 |
26-SEP-2023 | AGM | To Approve Re-Appointment of Mr. Raghavender Mateti (DIN: 06826653) As Non-Executive Independent Director of the Company for a Second Term of Five Consecutive Years. |
26-SEP-2023 | AGM | To Approve Re-Appointment of Mr. Narendra Singh Barhat (DIN: 00310306) As A Chairman And Managing Director of The Company. |
26-SEP-2023 | AGM | Revision In Remuneration Payable To Mrs. Kusum Narendra Singh Barhat (DIN 00310065), Executive Director Of The Company. |
26-SEP-2023 | AGM | Revision In Remuneration Payable To Mr. Ketankumar Harkantbhai Joshi (DIN :02089127), Whole Time Director Of The Company For His Remaining Term. |
26-SEP-2023 | AGM | Alteration of Articles of Association of the Company |
FAQs on Aristo Bio-Tech And Lifescience Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.